Andrew Miller

Andrew Miller

Company: Apros Therapeutics

Job title: Vice President of Immunology and Operations

Seminars:

Speaker Q&A 11:30 am

Read more

day: Day One

Tissue-Targeted TLR7 Agonists for Cancer Immunotherapy 11:05 am

Overview of various targeting approaches to localize TLR7 agonists to specific tissues for an improved therapeutic window (beyond intratumoral) Highlights of preclinical data around our most advanced program now in the clinic, which is an orally administered liver/GI-targeted TLR7 agonist for liver/GI malignancies Highlights of preclinical data on targeted TLR7 agonists in infectious diseaseRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.